Nahla Hamouda

Profile Picture of Nahla Hamouda
Title
Post-doc researcher,
Department
Regenerative medicine and cell biology, Pharmacology
Institution
Medical University of South Carolina

Education

  • PhD in Pharmacology

Research Interests

Undergraduate Medical Students   Clinical Pharmacology, Gastrointestinal Pharmacology, Immunotherapy   Pharmaceutical Sciences  

  View all research interests

Biography

Currently I am a Post-doc researcher in the Department of Regenerative Medicien and cell biology, College of Medicine , Medical University of South Carolina. I am MD, PhD in clinical Pharmacology at Alexandria Medical school, Egypt. I got my PhD from Japan in 2019. I am interested in the field of gastrointestinal pharmacology using experimental animal models. Teaching to graduate and undergraduate medical students is also a talent for me.

Homepages

Contact Information

  530 Meeting Street, Summit Place, 401-D 29403 Charleston, SC

  8434683382

Research
Not mentioned yet. (?)
List of Publications (19)
In 2023
19

1- Otsuki H, Jonan S, Tsujii T, Hamouda N, Amagase K. Effect of echinacoside as a palliative for irinotecan-induced intestinal mucositis. Integrative Physiology. 2023 Dec; 4(4): 429-440. Journal founders by The Herzen State Pedagogical University of Russia and Pavlov Institute of Physiology, Russian Academy of Sciences 2- Jonan S, Hamouda N, Fujiwara A, Iwata K, Fujita T, Kato S, Amagase K. Alleviative effects of glutamate against chemotherapeutic agent-induced intestinal mucositis. J Physiol Pharmacol. 2022 Aug;73(4). [Impact factor 2.589; Citation; 2]

Found on CV
18

International conference abstracts: 1- Amagase K, Sasaki R, Hamouda N, Ikeda I, Adachi Y. Factors involved in fibrosis of colorectal tissue due to chronic ulcerative colitis. Physiology, 2023, 38 (S1), 5734558.

Found on CV
17

2- Jonan S, Haneda M, Hamouda N, Amagase K. Glutamate alleviate the intestinal damage caused by chemotherapeutic agents. Physiology, 2023, 38 (S1), 5735213.

Found on CV
In 2022
16

3- Hamouda N, Jonan S, Fukatsu H, Amagase K. Protective mechanisms of glutamine in intestinal diseases. Integrative Physiology. 2022 Nov; 3(4):411-419. Journal founders by The Herzen State Pedagogical University of Russia and Pavlov Institute of Physiology, Russian Academy of Sciences.

Found on CV
15

4- Bekhit A.A, Nasralla S, El-Agroudy E, Hamouda N, Abd El-Fattah A, Bekhit S, Amagase K, Ibrahim T. Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative, European Journal of Pharmaceutical Sciences. 2022 Jan; 168. [Impact factor 5.112; Citation; 19]

Found on CV
In 2019
14

4- Hamouda N, Sano T, Shimakawa M, Matsumoto K, Amagase K, Higuchi K, Kato S. Pathogenic Role of Dysbiosis in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice. In DIGESTION 2019 Jan 1 (Vol. 99, No. 1, pp. 110-110).

Found on CV
In 2017
13

Since 2017, I have published 7 peer-reviewed journal articles with two articles as first author. I have h-index of 4, and 276 citations as calculated by Google scholar up till moment.

Found on CV
12

5- Kato S, Hamouda N, Kano Y, Oikawa Y, Tanaka Y, Matsumoto K, Amagase K, Shimakawa M. Probiotic Bifidobacterium Bifidum G9-1 attenuates 5-Fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related 2017

Found on CV
11

Exp Clin 6- Hamouda N, Sano T, Oikawa Y, Ozaki T, Shimakawa M, Matsumoto K, Amagase K, Higuchi K, Kato S. Apoptosis, Dysbiosis and expression of the development of 5-Fluorouracil-induced intestinal mucositis in mice. Basic Clin Pharmacol Toxicol. 2017 Sep;121(3):159-168. [Impact factor 3.688; Citation; 98] inflammatory cytokines are sequential events in 7- Tsukahara T, Hamouda N, Utsumi D, Matsumoto K, Amagase K, Kato S. G protein-coupled receptors 35 contributes to mucosal repair in mice via migration of colonic epithelial cells. Pharmacol Res. 2017 Sep; 123:27-39. [ Impact factor 9.3; Citation; 41]

Found on CV
10

The FASEB Journal 2017, 31(S1) 1049.1-1049.1

Found on CV
9

Contributes to Mucosal Healing in Mouse Colonic Epithelial Cells. The FASEB Journal 2017, 31(S1)1043.2-1043.2.

Found on CV
In 2016
8

7- Kato S, Hamouda N, Sano T, Amagase K, Higuchi K. Sequential Role of Apoptosis, Gram-Negative Enterobacteria, and Inflammatory Cytokines in the Pathogenesis of 5-Fluorouracil-Induced Intestinal Mucositis in Mice. In GASTROENTEROLOGY 2016 Apr 1 (Vol. 150, No. 4, pp. S897-S897).

Found on CV
7

Contributes to Mucosal Healing in Mouse Colonic Epithelial Cells. Gastroenterology. 2016 Apr 1;150(4): S490

Found on CV
6

9- Kato S, Hamouda N, Sano T, Amagase K, Higuchi K. Sequential Role of Apoptosis, Gram-Negative Enterobacteria, in Mice. the Pathogenesis of 5-Fluorouracil-Induced Intestinal Mucositis Inflammatory Cytokines and Gastroenterology. 2016 Apr 1;150(4): S897. in

Found on CV
Unspecified
5

Oct;44(10):1017-1025. [ Impact factor 2.98; Citation; 67] inflammatory responses.

Found on CV
4

3- Amagase K, Hamouda N, Masuda Y, Kato D, Matsumoto K, Kato S. New therapeutic strategy for amino acid: prophylactic and therapeutic effect of monosodium glutamate against gastrointestinal inflammation. Gastroenterology.

Found on CV
3

5- Kato S, Hamouda N, Utsumi D, Tsukahara T, Matsumoto K, Amagase K. Sequential role of apoptosis, Gram-negative enterobacteria, and inflammatory cytokines in the pathogenesis of 5-Fluorouracil-induced intestinal mucositis in mice.

Found on CV
2

6- Tsukahara T, Hamouda N, Utsumi D, Matsumoto K, Amagase K, Kato S. G Protein-Coupled Receptor 35 (GPR35)

Found on CV
1

8- Tsukahara T, Hamouda N, Utsumi D, Matsumoto K, Amagase K, Kato S. G Protein-Coupled Receptor 35 (GPR35)

Found on CV
Search Profiles
Colleagues
Profile Picture of Cassandra Clift
Medical University of South Carolina
Profile Picture of Eric Baker
Medical University of South Carolina
Profile Picture of Daniel Sprague
Medical University of South Carolina
Recommended Grants